Joint Department of Physics, The Royal Marsden NHS Foundation Trust, Fulham Road, London, SW3 6JJ, UK.
Radiology Department, Royal Brompton and Harefield NHS Foundation Trust, Sydney Street, London, SW3 6NP, UK.
J Cardiovasc Comput Tomogr. 2017 Jul-Aug;11(4):268-273. doi: 10.1016/j.jcct.2017.05.002. Epub 2017 May 8.
Little real-world radiation dose data exist for the majority of cardiovascular CT. Some data have been published for coronary CT angiography (coronary CTA) specifically, but they invariably arise from high-volume centres with access to the most recent technology.
The aim of this study was to document real-world radiation doses for coronary CTA in the United Kingdom, and to establish their relationship to clinical protocol selection, acquisition heart rate, and scanner technology.
A dose survey questionnaire was distributed to members of the British Society of Cardiovascular Imaging and other UK cardiac CT units. All participating centres collected data for consecutive coronary CTA cases over one month. The survey captured information about the exam conducted, patient demographics, pre-scan details such as beta-blocker administration, acquisition heart rate and scan technique, and post-scan dose indicators - series volumetric CT dose index (CTDI), series dose-length product (DLP), and exam DLP.
Fifty centres provided data on a total of 1341 coronary CTA exams. Twenty-nine centres (58%) performed at least 20 coronary CTA scans in the collection period. The median BMI, acquisition heart rate and exam DLP were 28 kg/m, 60 bpm and 209 mGycm respectively. The corresponding effective dose was estimated as 5.9 mSv using a conversion factor of 0.028 mSv/mGycm. There was no statistically significant difference in radiation dose between low and high-volume centres. Median exam DLP increased with the acquisition heart rate due to the selection of wider temporal windows. The highest exam DLPs were obtained on the older scanner technology.
This study provides baseline data for benchmarking practice, optimizing radiation dose and improving service quality locally.
大多数心血管 CT 检查的实际辐射剂量数据很少。虽然已经有一些关于冠状动脉 CT 血管造影(冠状动脉 CTA)的特定数据发表,但这些数据无一例外地来自具有最新技术的大容量中心。
本研究旨在记录英国冠状动脉 CTA 的实际辐射剂量,并确定其与临床方案选择、采集心率和扫描仪技术的关系。
向英国心血管成像学会的成员和其他英国心脏 CT 单位分发了一份剂量调查问卷。所有参与中心在一个月内连续收集冠状动脉 CTA 病例的数据。该调查收集了关于进行的检查、患者人口统计学、扫描前的详细信息(如β受体阻滞剂的使用)、采集心率和扫描技术以及扫描后剂量指标(系列容积 CT 剂量指数(CTDI)、系列剂量长度乘积(DLP)和检查 DLP)的信息。
50 个中心提供了总共 1341 例冠状动脉 CTA 检查的数据。在收集期间,29 个中心(58%)进行了至少 20 次冠状动脉 CTA 扫描。中位数 BMI、采集心率和检查 DLP 分别为 28kg/m2、60 次/分和 209mGycm。使用 0.028mSv/mGycm 的转换因子,有效剂量估计为 5.9mSv。低容量和高容量中心之间的辐射剂量没有统计学上的显著差异。由于选择了更宽的时间窗,检查 DLP 的中位数随采集心率的增加而增加。最旧的扫描仪技术获得了最高的检查 DLP。
本研究为基准实践、优化辐射剂量和提高当地服务质量提供了基线数据。